Tuula Heinonen

2.3k total citations
60 papers, 986 citations indexed

About

Tuula Heinonen is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Cancer Research. According to data from OpenAlex, Tuula Heinonen has authored 60 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Health, Toxicology and Mutagenesis and 11 papers in Cancer Research. Recurrent topics in Tuula Heinonen's work include Pharmacogenetics and Drug Metabolism (8 papers), Carcinogens and Genotoxicity Assessment (8 papers) and 3D Printing in Biomedical Research (7 papers). Tuula Heinonen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Carcinogens and Genotoxicity Assessment (8 papers) and 3D Printing in Biomedical Research (7 papers). Tuula Heinonen collaborates with scholars based in Finland, Czechia and United States. Tuula Heinonen's co-authors include Hannu Eskola, Marika Mannerström, Antti Zitting, Harri Vainio, Jertta‐Riina Sarkanen, Tarja Toimela, Wilhelm Gaus, Timo Ylikomi, Jing Zou and Ilmari Pyykkö and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tuula Heinonen

59 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tuula Heinonen Finland 17 211 165 153 114 106 60 986
Byung‐Ju Choi South Korea 15 263 1.2× 101 0.6× 127 0.8× 40 0.4× 49 0.5× 28 1.2k
Yuko Doi Japan 21 390 1.8× 92 0.6× 67 0.4× 69 0.6× 102 1.0× 76 1.6k
Yōko Kawamura Japan 19 189 0.9× 307 1.9× 94 0.6× 137 1.2× 28 0.3× 88 1.2k
Yan Kong China 20 366 1.7× 174 1.1× 34 0.2× 171 1.5× 82 0.8× 62 1.1k
Mahalaxmi Iyer India 26 568 2.7× 94 0.6× 113 0.7× 28 0.2× 102 1.0× 65 2.1k
Koel Chaudhury India 32 623 3.0× 233 1.4× 56 0.4× 139 1.2× 148 1.4× 98 2.8k
Yu‐Dong Xu China 20 448 2.1× 80 0.5× 150 1.0× 101 0.9× 55 0.5× 59 1.4k
Adam Hołownia Poland 18 337 1.6× 53 0.3× 62 0.4× 63 0.6× 68 0.6× 82 1.0k
Hongsheng Bi China 21 389 1.8× 122 0.7× 77 0.5× 183 1.6× 74 0.7× 135 1.8k
Shiek S. S. J. Ahmed India 17 358 1.7× 105 0.6× 59 0.4× 22 0.2× 63 0.6× 74 1.1k

Countries citing papers authored by Tuula Heinonen

Since Specialization
Citations

This map shows the geographic impact of Tuula Heinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuula Heinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuula Heinonen more than expected).

Fields of papers citing papers by Tuula Heinonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuula Heinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuula Heinonen. The network helps show where Tuula Heinonen may publish in the future.

Co-authorship network of co-authors of Tuula Heinonen

This figure shows the co-authorship network connecting the top 25 collaborators of Tuula Heinonen. A scholar is included among the top collaborators of Tuula Heinonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuula Heinonen. Tuula Heinonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Efimov, Alexander, Céline Frochot, Bauyrzhan Myrzakhmetov, et al.. (2024). LASU: An efficient and stable phthalocyanine dye with tolerable safety profile for self-disinfecting anti-COVID textiles activated by ambient light. Photodiagnosis and Photodynamic Therapy. 45. 103978–103978. 5 indexed citations
2.
Vaali, Kirsi, et al.. (2023). In Search of Clinical Markers: Indicators of Exposure in Dampness and Mold Hypersensitivity Syndrome (DMHS). Journal of Fungi. 9(3). 332–332. 1 indexed citations
3.
Toimela, Tarja, et al.. (2022). Direct Contraction Force Measurements of Engineered Cardiac Tissue Constructs With Inotropic Drug Exposure. Frontiers in Pharmacology. 13. 871569–871569. 2 indexed citations
4.
Mannerström, Marika, et al.. (2022). New approach methods for assessing indoor air toxicity. Current Research in Toxicology. 3. 100090–100090. 4 indexed citations
5.
Li, Xiang‐Guo, Tarja Toimela, Tuula Heinonen, et al.. (2021). Association between [68Ga]NODAGA-RGDyK uptake and dynamics of angiogenesis in a human cell-based 3D model. Molecular Biology Reports. 48(6). 5347–5353. 2 indexed citations
6.
Dvořáková, Markéta, et al.. (2020). Safety testing of adult novelties using in vitro methods. Regulatory Toxicology and Pharmacology. 117. 104780–104780. 5 indexed citations
7.
Kejlová, Kristína, Hana Bendová, Markéta Dvořáková, et al.. (2020). Toxicological testing of a photoactive phthalocyanine-based antimicrobial substance. Regulatory Toxicology and Pharmacology. 115. 104685–104685. 1 indexed citations
8.
Mannerström, Marika, et al.. (2020). Cytotoxicity of Water Samples Condensed from Indoor Air: An Indicator of Poor Indoor Air Quality. Trepo - Institutional Repository of Tampere University. 6(4). 120–130. 4 indexed citations
9.
Zurlinden, Todd J., Katerine S. Saili, Nancy Baker, et al.. (2020). A cross-platform approach to characterize and screen potential neurovascular unit toxicants. Reproductive Toxicology. 96. 300–315. 3 indexed citations
10.
Virtanen, A., Kati Tihtonen, Tarja Toimela, et al.. (2020). Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies. Pregnancy Hypertension. 22. 7–13. 5 indexed citations
11.
Sarkanen, Jertta‐Riina, et al.. (2020). Development of novel human in vitro vascularized adipose tissue model with functional macrophages. Cytotechnology. 72(5). 665–683. 7 indexed citations
12.
Stuard, Sharon B. & Tuula Heinonen. (2018). Relevance and Application of Read‐Across – Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session. Basic & Clinical Pharmacology & Toxicology. 123(S5). 37–41. 15 indexed citations
14.
Penttinen, Kirsi, Tuula Heinonen, Mari Pekkanen-Mattila, et al.. (2017). Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct. Cytotechnology. 69(5). 785–800. 23 indexed citations
15.
Mannerström, Marika, Jing Zou, Tarja Toimela, Ilmari Pyykkö, & Tuula Heinonen. (2016). The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes. Toxicology in Vitro. 37. 113–120. 26 indexed citations
16.
Adcock, Ian M., François Busquet, Kevin M. Crofton, et al.. (2016). Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations. Drug Discovery Today. 22(2). 327–339. 60 indexed citations
17.
Sarkanen, Jertta‐Riina, et al.. (2016). Differentiation of human adipose stromal cells in vitro into insulin-sensitive adipocytes. Cell and Tissue Research. 366(1). 63–74. 6 indexed citations
18.
19.
Zou, Jing, Hao Feng, Marika Mannerström, Tuula Heinonen, & Ilmari Pyykkö. (2014). Toxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line. Journal of Nanobiotechnology. 12(1). 52–52. 42 indexed citations
20.
Sarkanen, Jertta‐Riina, Bettina Mannerström, Hannu Kuokkanen, et al.. (2012). Adipose Stromal Cell Tubule Network Model Provides a Versatile Tool for Vascular Research and Tissue Engineering. Cells Tissues Organs. 196(5). 385–397. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026